Studies in animal models show that, beyond stimulating erythropoiesis, EPO can also regulate fat mass and monocyte–macrophage-derived cell response in obesity-associated inflammation and bone remodeling. Here, EPO is linked to obesity due to melanocortin 4 receptor deficiency.